Michela Guardascione

8PUBLICATIONS
30CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Gene and molecular therapyPharmaceutical delivery technologiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 26, 2026
Probe-Based Confocal Laser Endomicroscopy During Immune Checkpoint Inhibitor Therapy: A Translational Framework Linking Intestinal Barrier Function, Microbiota, and Clinical Outcomes.

|Aug 27, 2026
Clinical Validity of Imatinib Therapeutic Drug Monitoring in a Real-World Italian Cohort of Gastrointestinal Stromal Tumors and the Role of Patients' Sex.

|Nov 13, 2023
Therapeutic drug monitoring and pharmacogenetics to tune imatinib exposure in gastrointestinal stromal tumor patients: hurdles and perspectives for clinical implementation.

Sara Gagno, Chiara Dalle Fratte, Bianca Posocco

|Jun 15, 2023
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure.

Sara Gagno, Angela Buonadonna, Chiara Dalle Fratte

|Feb 25, 2023
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis.

Chiara Dalle Fratte, Jerry Polesel, Sara Gagno

|Sep 30, 2022
CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients.

Chiara Dalle Fratte, Sara Gagno, Rossana Roncato

Pageof 2

Frequent Collaborators

5 joint publications

Giuseppe Toffoli

5 joint publications

Fabio Puglisi

5 joint publications

Erika Cecchin

4 joint publications

Angela Buonadonna